NCT02762461

Brief Summary

This project will investigate worsening of symptoms in endometriosis patients undergoing artificial reproductive techniques (ART). The study compares patients with peritoneal/ovarian and deep infiltrating endometriosis to relevant reference groups. Symptoms are monitored with a questionnaire with the categories quality of life, pain and bowel habits. The EHP-30® questionnaire is included in the questionnaire.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
154

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2016

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2016

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

April 28, 2016

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 5, 2016

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2018

Completed
Last Updated

April 6, 2018

Status Verified

April 1, 2018

Enrollment Period

2.2 years

First QC Date

April 28, 2016

Last Update Submit

April 5, 2018

Conditions

Keywords

Fertilization in VitroSperm Injections, IntracytoplasmicEndometriosis

Outcome Measures

Primary Outcomes (1)

  • Endometriosis Health Profile 30® (EHP-30®)

    The core instruments have five scale scores covering: Pain (11 questions), control and powerlessness (6 questions), social support (4 questions), emotional well-being (6 questions), self-image (3 questions).

    Groups undergoing ART: Change from baseline measures before stimulation during ART to ten days after aspiration. Reference group not undergoing ART: Change from baseline measures to four weeks later.

Secondary Outcomes (2)

  • Pain (NRS scale: 0-10)

    Groups undergoing ART: Change from baseline measures before stimulation during ART to ten days after aspiration. Reference group not undergoing ART: Change from baseline measures to four weeks later.

  • Bowel habits

    Groups undergoing ART: Change from baseline measures before stimulation during ART to ten days after aspiration. Reference group not undergoing ART: Change from baseline measures to four weeks later.

Study Arms (3)

Exposed group

Women with peritoneal/ovarian endometriosis and DIE (rectovaginal and rectosigmoid endometriosis) undergoing ART (IVF or ICSI).

Procedure: IVF or ICSI

Reference group 1

Women with infertility because of factors other than endometriosis, e.g. male factor, undergoing ART (IVF or ICSI).

Procedure: IVF or ICSI

Reference group 2

Women with medically treated endometriosis not undergoing ART.

Interventions

IVF or ICSIPROCEDURE
Exposed groupReference group 1

Eligibility Criteria

AgeUp to 40 Years
Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Women with endometriosis under the age of 40 years.

You may qualify if:

  • Female
  • \< 40 years
  • Either undergoing ART (IVF or ICSI) with or without endometriosis or medically treated endometriosis

You may not qualify if:

  • \> 40 years

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Gynaecology and Obstetrics, Aarhus University Hospital

Aarhus, 8000, Denmark

Location

MeSH Terms

Conditions

Endometriosis

Interventions

Sperm Injections, Intracytoplasmic

Condition Hierarchy (Ancestors)

Genital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Intervention Hierarchy (Ancestors)

Fertilization in VitroReproductive Techniques, AssistedReproductive TechniquesTherapeuticsInvestigative Techniques

Study Officials

  • Mie Mathiasen, Student

    University of Aarhus

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
4 Weeks
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 28, 2016

First Posted

May 5, 2016

Study Start

February 1, 2016

Primary Completion

April 1, 2018

Study Completion

April 1, 2018

Last Updated

April 6, 2018

Record last verified: 2018-04

Data Sharing

IPD Sharing
Will not share

Locations